CYTOKINETICS INC - COMMON STOCK (CYTK)

CUSIP: 23282W605

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
123,724,358
Total 13F shares
104,802,748
Share change
-1,395,933
Total reported value
$5,076,619,614
Put/Call ratio
33%
Price per share
$48.45
Number of holders
271
Value change
-$48,250,542
Number of buys
144
Number of sells
105

Security key

23282W605

Report period

Q3 2022

Institutions

271

Top holders

10

Top shareholders of CYTK - CYTOKINETICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
11%
13,413,296
$527,008,000 30 Jun 2022
13F
FMR LLC
13F
Company
10%
12,803,861
$503,063,000 30 Jun 2022
13F
VANGUARD GROUP INC
13F
Company
7.2%
8,960,220
$352,047,000 30 Jun 2022
13F
CITADEL ADVISORS LLC
13F
Company
3.8%
4,642,827
$182,416,000 30 Jun 2022
13F
STATE STREET CORP
13F
Company
3.6%
4,504,226
$176,971,000 30 Jun 2022
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.1%
3,868,632
$151,998,000 30 Jun 2022
13F
Polar Capital Holdings Plc
13F
Company
2.4%
3,026,648
$118,917,000 30 Jun 2022
13F
LORD, ABBETT & CO. LLC
13F
Company
2.4%
2,990,151
$117,483,000 30 Jun 2022
13F
RTW INVESTMENTS, LP
13F
Company
2.1%
2,561,182
$100,629,000 30 Jun 2022
13F
PFM Health Sciences, LP
13F
Company
2%
2,465,016
$96,850,000 30 Jun 2022
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
1.8%
2,245,038
$88,208,000 30 Jun 2022
13F
PICTET ASSET MANAGEMENT SA
13F
Company
1.8%
2,207,888
$86,748,000 30 Jun 2022
13F
Boxer Capital, LLC
13F
Company
1.7%
2,100,000
$82,509,000 30 Jun 2022
13F
Logos Global Management LP
13F
Company
1.4%
1,750,000
$68,758,000 30 Jun 2022
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
1.4%
1,699,426
$66,770,000 30 Jun 2022
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.3%
1,647,654
$64,736,000 30 Jun 2022
13F
MORGAN STANLEY
13F
Company
1.2%
1,500,105
$58,939,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
1,483,522
$58,287,000 30 Jun 2022
13F
MARSHALL WACE, LLP
13F
Company
1.1%
1,353,137
$53,164,000 30 Jun 2022
13F
Artal Group S.A.
13F
Company
1%
1,275,000
$50,095,000 30 Jun 2022
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.94%
1,160,315
$45,589,000 30 Jun 2022
13F
Bank of New York Mellon Corp
13F
Company
0.92%
1,136,945
$44,671,000 30 Jun 2022
13F
FRANKLIN RESOURCES INC
13F
Company
0.88%
1,093,580
$42,966,000 30 Jun 2022
13F
NORTHERN TRUST CORP
13F
Company
0.79%
971,666
$38,176,000 30 Jun 2022
13F
Commodore Capital LP
13F
Company
0.72%
893,646
$35,111,000 30 Jun 2022
13F
Hood River Capital Management LLC
13F
Company
0.69%
851,905
$33,471,000 30 Jun 2022
13F
NORGES BANK
13F
Company
0.61%
752,734
$29,574,919 30 Jun 2022
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.54%
673,268
$26,453,000 30 Jun 2022
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.53%
653,513
$25,677,000 30 Jun 2022
13F
GREAT POINT PARTNERS LLC
13F
Company
0.49%
610,000
$23,967,000 30 Jun 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.49%
606,995
$23,849,000 30 Jun 2022
13F
Assenagon Asset Management S.A.
13F
Company
0.48%
589,274
$23,153,000 30 Jun 2022
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.45%
561,342
$22,058,000 30 Jun 2022
13F
Invesco Ltd.
13F
Company
0.44%
547,588
$21,515,000 30 Jun 2022
13F
Integral Health Asset Management, LLC
13F
Company
0.42%
525,000
$20,627,000 30 Jun 2022
13F
S.c.a. Candriam
13F
Individual
0.42%
520,476
$20,449,000 30 Jun 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.4%
497,739
$19,556,000 30 Jun 2022
13F
HealthCor Management, L.P.
13F
Company
0.39%
485,600
$19,079,000 30 Jun 2022
13F
WASATCH ADVISORS LP
13F
Company
0.38%
475,525
$18,683,000 30 Jun 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.38%
470,753
$18,496,000 30 Jun 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.38%
464,400
$18,246,000 30 Jun 2022
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.36%
440,142
$17,294,000 30 Jun 2022
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.35%
431,423
$16,950,000 30 Jun 2022
13F
Finepoint Capital LP
13F
Company
0.34%
419,433
$16,480,000 30 Jun 2022
13F
Cormorant Asset Management, LP
13F
Company
0.32%
400,000
$15,716,000 30 Jun 2022
13F
Rock Springs Capital Management LP
13F
Company
0.32%
400,000
$15,716,000 30 Jun 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.29%
361,009
$14,184,000 30 Jun 2022
13F
Bain Capital Public Equity Management II, LLC
13F
Company
0.28%
340,926
$13,395,000 30 Jun 2022
13F
Lisanti Capital Growth, LLC
13F
Company
0.27%
333,272
$13,094,000 30 Jun 2022
13F
BARCLAYS PLC
13F
Company
0.27%
328,281
$12,898,000 30 Jun 2022
13F

Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2022

As of 30 Sep 2022, CYTOKINETICS INC - COMMON STOCK (CYTK) was held by 271 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 104,802,748 shares. The largest 10 holders included BlackRock Inc., FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, LORD, ABBETT & CO. LLC, Polar Capital Holdings Plc, RTW INVESTMENTS, LP, PFM Health Sciences, LP, and PICTET ASSET MANAGEMENT SA. This page lists 272 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
255
Q3 2022 holders
271
Holder diff
16
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .